Although the general population now has at least some immunity against COVID-19, the consequences of severe disease are frequently overlooked for certain patient populations, such as those with ...
NEXSPIKE is Moderna’s third product to receive a positive CHMP opinion alongside Spikevax (COVID-19 Vaccine, mRNA) and ...
From COVID-19 to the seasonal flu and RSV, vaccinations for respiratory viruses are typically delivered via intramuscular injection, which generates antibodies in the bloodstream. But the first line ...
The US Food and Drug Administration has issued updated guidance for companies that plan to adapt their Covid-19 medical products -- including vaccines, tests and therapeutics -- to address the ...
- First in human Phase 1 study evaluating single/multiple doses of ALG-097558 in healthy volunteers is ongoing - Aligos plans to continue to seek external funding to advance ALG-097558 beyond the ...
- KOSTAIVE represents a significant advancement in vaccine technology, demonstrating superior immunogenicity and antibody persistence for up to 12 months post-vaccination compared to conventional mRNA ...
NEW YORK (WABC) -- There are rising concerns about the new omicron variant, as cases have now been confirmed in more than half the U.S. Early anecdotal reports seem to indicate those infected are ...
Red Queen Therapeutics, Inc., a biotechnology research company, filed for bankruptcy within a week of bankruptcy filing by ...
The agency also is reviewing safety of immunizations for RSV, according to manufacturers of the therapies who have been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback